Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligometastatic”

309 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 309 results

Not applicableLooking for participantsNCT04854213
What this trial is testing

PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)

Who this might be right for
Colorectal Cancer Metastatic
National Cancer Institute, Naples 25
Testing effectiveness (Phase 2)Looking for participantsNCT06180356
What this trial is testing

Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression

Who this might be right for
Ovarian CancerOligometastatic DiseaseSerous Ovarian Tumor
MedSIR 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04655365
What this trial is testing

Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 50
Testing effectiveness (Phase 2)Looking for participantsNCT06439888
What this trial is testing

Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer

Who this might be right for
Oligometastatic DiseaseSolid Tumor, Adult
Gustave Roussy, Cancer Campus, Grand Paris 58
Testing effectiveness (Phase 2)UnknownNCT05055583
What this trial is testing

Toripalimab in Combination With Platinum-based Chemotherapy for Mutation-negative Stage IV Oligometastatic NSCLC

Who this might be right for
NSCLC Stage IVOligometastasis
Tang-Du Hospital 30
Not applicableNot Yet RecruitingNCT05707468
What this trial is testing

Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer

Who this might be right for
Oligometastatic Prostate Carcinoma
Changhai Hospital 200
Testing effectiveness (Phase 2)Looking for participantsNCT06690528
What this trial is testing

Conversion Surgery Vs. Palliative Care in Pancreatic Cancer Oligometastatic to the Liver

Who this might be right for
Pancreatic Cancer Metastatic
Azienda Ospedaliera di Padova 56
Large-scale testing (Phase 3)Looking for participantsNCT05303714
What this trial is testing

PIPAC in Multimodal Therapy for Patients with Oligometastatic Peritoneal Gastric Cancer

Who this might be right for
Oligometastatic Gastric Adenocarcinoma
Azienda Ospedaliera Universitaria Integrata Verona 98
Not applicableStudy completedNCT03604211
What this trial is testing

SBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution Experience

Who this might be right for
Prostate Cancer RecurrentProstate CancerLymph Node Metastases
Kantonsspital Graubuenden 25
Large-scale testing (Phase 3)Active Not RecruitingNCT03525288
What this trial is testing

PSMA-PET Guided Radiotherapy

Who this might be right for
Prostate Cancer
Centre hospitalier de l'Université de Montréal (CHUM) 130
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06502080
What this trial is testing

Consolidative Radiotherapy (CSRT) in Patients With Oligometastatic/Locally Advanced Unresectable Bilary Tract Cancer (BTC)

Who this might be right for
Biliary Tract Cancer
Shanghai Zhongshan Hospital 128
Testing effectiveness (Phase 2)Active Not RecruitingNCT03654131
What this trial is testing

Microwave Ablation Versus Stereotactic Body Radiotherapy for Colorectal Liver Metastases in Oligometastatic Disease: a Prospective, Randomised, Phase 2 Trial

Who this might be right for
Colorectal CarcinomaLiver Metastases
Rigshospitalet, Denmark 100
Testing effectiveness (Phase 2)Study completedNCT02316002
What this trial is testing

Phase II Study of Pembrolizumab After Curative Intent Treatment for Oligometastatic Non-Small Cell Lung Cancer

Who this might be right for
Oligometastatic Non-small Cell Lung Cancer (NSCLC)
Abramson Cancer Center at Penn Medicine 51
Not applicableWithdrawnNCT03301701
What this trial is testing

Feasibility Trial in Men With Hormone Sensitive Oligometastatic Prostate Cancer

Who this might be right for
Hormone Sensitive Oligometastatic Prostate Cancer
Dr. Patrick Cheung
Large-scale testing (Phase 3)Not Yet RecruitingNCT07537946
What this trial is testing

Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)Metastases
Tongji Hospital 400
Not applicableUnknownNCT02581670
What this trial is testing

Study on SBRT for Inoperable Lung and Liver Oligometastases From Breast Cancer

Who this might be right for
Breast CancerMetastasis to LiverMetastasis to Lung
Istituto Clinico Humanitas 65
Not applicableStudy completedNCT07446946
What this trial is testing

Surgical Management of Pancreatic Cancer With Liver Metastasis (Oligometastasis)

Who this might be right for
Pancreatic Cancer With Liver Metastases
Richard Hunger 68,303
Testing effectiveness (Phase 2)Active Not RecruitingNCT04190446
What this trial is testing

Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate Cancer

Who this might be right for
Metastatic Prostate AdenocarcinomaOligometastatic Prostate CarcinomaProstate Adenocarcinoma+2 more
Mayo Clinic 84
Not applicableStudy completedNCT02816983
What this trial is testing

SBRT for Oligometastatic Castration-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Mayo Clinic 89
Not applicableLooking for participantsNCT04926584
What this trial is testing

Prospective Trial of Induction Immunotherapy in Locally Advanced or Oligometastatic NSCLC Without a Primary Curative Option

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Klinikum Esslingen 50
Load More Results